// App-Quantinova.ai

: MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Researchers

Presenter

  • Howard S. Oster

Principal Investigators

  • Alexandra Smith

  • Ge Yu

  • Bander Abu Shrkihe

  • Shoham Baruch

  • Albert Kolomansky

  • Jonathan Ben-Ezra

  • Shachar Naor

  • Pierre Fenaux

  • Argiris Symeonidis

  • Reinhard Stauder

  • Jaroslav Cermak

  • Guillermo Sanz

  • Eva Hellstrm-Lindberg

  • Luca Malcovati

  • Saskia Langemeijer

  • Ulrich Germing

  • Mette Skov Holm

  • Krzysztof Madry

  • Agnes Guerci-Bresler

  • Dominic Culligan

  • Laurence Sanhes

  • Juliet Mills

  • Ioannis Kotsianidis

  • Corine van Marrewijk

  • David Bowen

  • Theo de Witte

  • Moshe Mittelman

Medical Centers

  • Department of Internal Medicine, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • Epidemiology and Cancer Statistics Group, Department of Health Sciences,University of York,York,United Kingdom

  • Internal diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Department of Plastic Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

  • Service d'Hematologie Seniors/Hopital Saint-Louis, Universite Paris 7, Paris, France

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Rheumatology Department, Hospital Universitari i Politecnic la Fe, Valencia, Spain

  • Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden

  • Department of Molecular Medicine & Hematology Oncology, Piazzale Golgi 2, Italy

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Medical University of Warsaw, Warsaw, Poland

  • Hematology department, CHU Brabois, Vandoeuvre les Nancy, France

  • Dept of Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Service d'Hématologie, Centre Hospitalier de Perpignan, Perpignan, FRA

  • Hematology,Acute Hospitals NHS Trust and University of Birmingham,Birmingham,United Kingdom

  • Second Department of Surgery, Democritus University of Thrace, Alexandroupolis, Greece

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

Locations

  • Israel

  • United Kingdom

  • France

  • Greece

  • Austria

  • Czech Republic

  • Spain

  • Sweden

  • Italy

  • Netherlands

  • Germany

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N-Acylethanolamine acid amidase

  • Creatinine

  • Mean corpuscular volume

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A